Skip to content

Introducing PIONEER: a project to harness big data in prostate cancer research

Omar M I, Roobol M J. Ribal M J, Abbott T, Agapow P-M, Araujo S, Asiimwe A, Auffray C, Balaur I, Beyer K, Bernini C, Bjartell A, Briganti A, Butler-Ransohoff J-E, Campi R, Cavelaars M, De Meulder B, Devecseri, Voss MD, Dimitropoulos K, Evans-Axelsson S, Franks B, Fullwood L, Horgan D, Smith E J, Kiran A, Kivinummi K, Lambrecht M, Lancet D, Lindgren P, MacLennan S, MacLennan S, Nogueira M M, Moen F, Moinat M, Papineni K, Reich C, Kristin Reiche, Rogiers S, Sartini C, van Bochove K, van Diggelen F, Van Hemelrijck M, Van Poppel H, Zong J, N’Dow J & The PIONEER Consortium

Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer, consisting of 32 private and public stakeholders from 9 countries across Europe to which the IHE contributes.

In this perspective piece published in Nature Reviews Oncology which constitutes the first peer-reviewed publication from the project you can read how based on a unique set of methodologies, PIONEER aims to advance the field of prostate cancer care with a particular focus on improving prostate-cancer-related outcomes, health system efficiency by streamlining patient management, and the quality of health and social care delivered to all men with prostate cancer and their families worldwide.

Read the article:

The PIONEER website:

For questions about PIONEER, please reach out to Thomas Hofmarcher

Nature Reviews Urology, 2020; 17: 351–362